Concurrent chemoradiotherapy using carboplatin/cetuximab regimen in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) not eligible for high-dose cisplatin (HD-DDP)

被引：0
|
作者：
Saigal, Kunal
Warsch, Sean
Mandalia, Amar
Samuels, Michael
Tolba, Khaled A.
Ikpeazu, Chukwuemeka
Kwon, Deukwoo
Santos, Edgardo S.
机构：
[1] Univ Miami, Miami, FL USA
[2] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16001
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pembrolizumab and radiotherapy for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) with contraindication to cisplatin therapy
    Sheth, S.
    Bauman, J. R.
    Deal, A.
    Chera, B.
    Shen, C.
    Galloway, T.
    Hackman, T.
    Blumberg, J.
    Yarbrough, W.
    Weissler, M.
    Hilliard, C.
    Mehra, R.
    Grilley-Olson, J.
    Weiss, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] Chemoradiotherapy with high-dose cisplatin compared with weekly cisplatin for locally advanced head and neck squamous cell carcinoma
    Hughes, Ryan T.
    Porosnicu, Mercedes
    Levine, Beverly J.
    Lycan, Thomas W., Jr.
    Shenker, Rachel F.
    Frizzell, Bart A.
    Greven, Kathryn M.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2021, 65 (06) : 796 - 805
  • [3] Safety and efficacy of concurrent carboplatin or cetuximab chemoradiation in cisplatin ineligible locally advanced head and neck squamous cell carcinoma
    Marinho, Joana
    Laranja, Andre
    Leao, Ines
    Joaquim, Ana
    Vieira, Claudia
    Dinis, Jose
    Soares, Andre
    Moreira, Diana
    ORAL ONCOLOGY, 2021, 118
  • [4] Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)'
    Hanemaaijer, S. H.
    Kok, I. C.
    Fehrmann, R. S. N.
    van der Vegt, B.
    Gietema, J. A.
    Plaat, B. E. C.
    Vugt, M. A. T. M.
    Vergeer, M. R.
    Voortman, J.
    Leemans, C. R.
    Buter, J.
    Langendijk, J. A.
    Oosting, S. F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] Correlation of deviation from intended cisplatin (CDDP) dose intensity with outcome in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) receiving concurrent chemoradiation (CRT)
    Liu, C. S.
    Elser, C.
    Huang, S.
    Pond, G. R.
    O'Sullivan, B.
    Chen, E. X.
    Waldron, J. N.
    Goldstein, D.
    Siu, L. L.
    Kim, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Reporting of endpoints and tracking of failures in randomized trials of radiotherapy or concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer (LA-HNSCC)
    Le Tourneau, C.
    Michiels, S.
    Gan, H.
    Siu, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] A randomized, multicenter, open phase II study of cetuximab with docetaxel, cisplatin as induction chemotherapy in unresectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
    Koh, Youngil
    Lee, Keun-Wook
    Kim, Sung-Bae
    Park, Kyong Hwa
    Shin, Sang Won
    Kang, Jin Hyoung
    Keam, Bhumsuk
    Lee, Se-Hoon
    Heo, Dae Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Efficacy and Safety of Aprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC): A Phase 2 Trial
    Zhang, Y.
    Yi, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S108 - S109
  • [9] Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
    Goshi Nishimura
    Takahide Taguchi
    Masahiro Takahashi
    Osamu Shiono
    Masanori Komatsu
    Daisuke Sano
    Kenichiro Yabuki
    Yasuhiro Arai
    Hideaki Takahashi
    Masaharu Hata
    Nobuhiko Oridate
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1315 - 1319
  • [10] Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
    Nishimura, Goshi
    Taguchi, Takahide
    Takahashi, Masahiro
    Shiono, Osamu
    Komatsu, Masanori
    Sano, Daisuke
    Yabuki, Kenichiro
    Arai, Yasuhiro
    Takahashi, Hideaki
    Hata, Masaharu
    Oridate, Nobuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) : 1315 - 1319
12345